PharmaVitae: Company Comparator Tool
Report Code:
IMHC0080
The Comparator Tool builds from the PharmaVitae profiles of the 50 leading pharma...
|
 |
02/29/2008 |
$45600.00 |
| |
|
|
|
Stakeholder Insight: Acute Coronary Syndromes Fresh look at ACS in Europe, what is the real picture?
Report Code:
DMHC2347
The face of ACS is changing. The ageing population and pressure of growing risk...
|
|
12/26/2007 |
$30400.00 |
| |
|
|
|
Stakeholder Insight: Acute Coronary Syndromes ACS in Europe, what is the best practice?
Report Code: DMHC2471
The face of ACS continues to change. The ageing population and pressure of growing...
|
|
12/25/2008 |
$30400.00 |
| |
|
|
|
The Clinical Chemistry And Immunodiagnostics Market: A 7-Country Market Survey
Report Code: V3PComplete
|
|
08/01/1997 |
$29400.00 |
| |
|
|
|
Commercial Insight: Solid organ transplantation - The impact of new biologics, generics and reformulations
Report Code: DMHC2456
The transplant immunosuppressant market has seen considerable growth in recent years,...
|
|
12/18/2008 |
$15400.00 |
| |
|
|
|
Commercial and Pipeline Insight: Influenza Vaccines - Pandemic threat revitalizes the sector
Report Code:
DMHC2280
The influenza vaccine market, sized at approximately $2.2 billion in 2006, yields many...
|
|
04/06/2007 |
$15200.00 |
| |
|
|
|
Pipeline/Commercial Insight: Supportive Care in Oncology - Significant growth opportunities exist in new supportive care indications
Report Code:
DMHC2297
Supportive care can be defined as those products used to prevent and/or treat the...
|
|
06/15/2007 |
$15200.00 |
| |
|
|
|
Commercial Insight: Depression - Atypical lifecycle management strategy rejuvenates depression market
Report Code:
DMHC2305
Novel pipeline drugs, lifecycle management of the current branded antidepressants, and...
|
|
06/27/2007 |
$15200.00 |
| |
|
|
|
Commercial Insight: Insomnia - Strong brand identity critical to differentiation in an increasingly crowded market
Report Code:
DMHC2306
Ambien has remained the clear leader in the insomnia market for over a decade, with...
|
|
06/27/2007 |
$15200.00 |
| |
|
|
|
Commercial Insight: Multiple Sclerosis - Continued growth makes the MS market a highly attractive investment
Report Code:
DMHC2307
The dynamic MS market continues to grow unabated; seven major market revenues...
|
|
06/27/2007 |
$15200.00 |
| |
|
|
|
Commercial Insight: Osteoporosis - Risk management and reformulation offer best defense against generic onslaught
Report Code:
DMHC2308
The osteoporosis market is due a major upheaval when market leader Fosamax...
|
|
06/27/2007 |
$15200.00 |
| |
|
|
|
Commercial Insight: Top 20 Cancer Therapy Brands - Sales of targeted therapies overtake cytotoxics in 2006
Report Code:
DMHC2299
Sales of the Top 20 cancer therapy brands in each of the seven major markets totaled...
|
|
07/02/2007 |
$15200.00 |
| |
|
|
|
Commercial Insight: Asthma & COPD - Combination products still have blockbuster potential
Report Code:
DMHC2310
Detailed analysis of the Asthma and COPD market. 10 year sales forecast for all major...
|
|
07/11/2007 |
$15200.00 |
| |
|
|
|
Commercial Insight: HIV - Reshaping Treatment Paradigms
Report Code:
DMHC2311
Detailed analysis of the antiretroviral therapy market. 10 year sales forecast for...
|
|
07/11/2007 |
$15200.00 |
| |
|
|
|
Commercial Insight: Antidyslipidemics - The competitive cost-conscious antidyslipidemics market presents challenges
Report Code:
DMHC2315
The restrictive, highly competitive antidyslipidemic market is going to become even...
|
|
07/11/2007 |
$15200.00 |
| |
|
|
|
Pipeline/Commercial Insight: Antihypertensives New class opportunity offset by key patent expiries
Report Code:
DMHC2314
Datamonitor expects the antihypertensives market to reach almost $40 billion, across...
|
|
07/12/2007 |
$15200.00 |
| |
|
|
|
Commercial and Pipeline Insight: Pediatric and Adolescent Vaccines - Substantial market expansion ahead
Report Code:
DMHC2313
The pediatric and adolescent vaccines market encompasses many different classes. DTP...
|
|
07/23/2007 |
$15200.00 |
| |
|
|
|
R&D Strategies: Incremental improvements and paradigm shifts in strategy are both necessary to boost productivity
Report Code:
DMHC2309
Waves of technological advancements have powered significant evolution in R&D from...
|
|
08/09/2007 |
$15200.00 |
| |
|
|
|